Dare Bioscience raises $16.5M, believes it regains Nasdaq equity compliance

Dare Bioscience, Inc.

Raised approx. $16.5M gross from ATM and equity line sales since Mar 31, 2025.
Believes stockholders' equity now exceeds $2.5M Nasdaq minimum for continued listing.
Will notify Nasdaq; no guarantee of regaining compliance.
Shares outstanding will be ~12.6M after the sales.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.